Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ROMIDEPSIN vs ROSUVASTATIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ROMIDEPSIN vs ROSUVASTATIN: Safety Overview

Metric ROMIDEPSIN ROSUVASTATIN
Total FAERS Reports 1,282 36,332
Deaths Reported 343 1,536
Death Rate 26.8% 4.2%
Hospitalizations 458 11,195
Average Patient Age 64.7 yrs 66.1 yrs
% Female Patients 46.5% 54.9%
FDA Approval Date Mar 13, 2020 Apr 1, 2020
Manufacturer Fresenius Kabi USA, LLC Umedica Laboratories USA Inc.
Route N/A ORAL
Marketing Status Prescription Prescription